跳至主要内容
临床试验/NCT02776826
NCT02776826已完成不适用

World Bleeding Disorders Registry Pilot Phase

World Federation of Hemophilia0 个研究点目标入组 356 人开始时间: 2016年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
356
主要终点
Proportion of HTCs which agree to participate in the pilot phase of the WBDR

研究概览

简要总结

The World Federation of Hemophilia (WFH) is conducting the pilot phase of an international, observational, World Bleeding Disorders Registry (WBDR). This pilot phase will assess the feasibility of conducting an expanded WBDR to more centres with a more comprehensive case report form, around the world.

详细描述

The pilot phase of the WBDR is an observational disease registry of patients with hemophilia. Forty hemophilia treatment centres (HTCs), of varying levels of economic development (emerging, mid-level and established), that have data entry capabilities and the ability to obtain the required data on patients in English, were invited to participate in the pilot phase. Participating HTCs will complete a Minimal Data Set (MDS) of data on approximately 10 patients each.

A series of performance indicators have been identified by the Steering committee and will be used to assess the feasibility of expanding the pilot phase to the WBDR. The performance indicators include: proportion of HTCs invited that are willing to participate; proportion of participating HTCs who successfully obtain necessary regulatory approvals; proportion of patients approached who consent to participate; proportion of enrolled patients on which data collection and database entry is successful.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients of participating Hemophilia Treatment Centres with Hemophilia A or B.
  • Ability to provide data in English

排除标准

  • 未提供

结局指标

主要结局

Proportion of HTCs which agree to participate in the pilot phase of the WBDR

时间窗: 6 months

This is be measured by the number of HTCs who agree to participate, divided by the number of HTCs invited.

Proportion of participating HTCs who successfully obtain necessary regulatory approval

时间窗: 6 months

This will be measured by the number of HTCs who obtain approval, divided by the number of HTCs who have agreed to participate in the pilot phase of the WBDR.

Proportion of patients who agree to participate in this pilot phase of the WBDR.

时间窗: 6 months

This will be measured by the number of patients who provided consent to participate, divided by the number of patients who were approached to participate.

Proportion of enrolled patients on which data collection and database entry is successful.

时间窗: 6 months

This will be measured by the number of patients on who data is collected and entered successfully into the database, divided by the number of patients who are enrolled in the pilot phase of the WBDR.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验